CLASS ACTION UPDATE for BIRD, FULC and VIRT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / May 30, 2023 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

BIRD Shareholders Click Here: https://zlk.com/pslra-1/allbirds-lawsuit-submission-form?prid=40030&wire=1
FULC Shareholders Click Here: https://zlk.com/pslra-1/fulcrum-lawsuit-submission-form?prid=40030&wire=1
VIRT Shareholders Click Here: https://zlk.com/pslra-1/virtu-lawsuit-submission-form?prid=40030&wire=1

* ADDITIONAL INFORMATION BELOW *

Allbirds, Inc. (NASDAQ:BIRD)

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Allbirds Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's November 2021 initial public offering; and/or (b) Allbirds securities between November 4, 2021 and March 9, 2023, inclusive.
Lead Plaintiff Deadline : June 12, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/allbirds-lawsuit-submission-form?prid=40030&wire=1

According to the filed complaint, (1) Allbirds was overemphasizing products that extended beyond the Company's core offerings; (2) the Company's non-core products had a narrower appeal and were not resonating with customers as well as the Company's core products; (3) Allbirds was underinvesting in its core consumers' favorite products to push the Company's newer products with narrower appeal; (4) underinvesting in Allbirds' core products was negatively impacting the Company's sales; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Fulcrum Therapeutics, Inc. (NASDAQ:FULC)

FULC Lawsuit on behalf of: investors who purchased March 3, 2022 - March 8, 2023
Lead Plaintiff Deadline : June 27, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/fulcrum-lawsuit-submission-form?prid=40030&wire=1

According to the filed complaint, during the class period, Fulcrum Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the preclinical data submitted in support of FTX-6058 (an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies) showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; (iii) accordingly, the Company had overstated FTX-6058's clinical and/or commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Virtu Financial, Inc. (NASDAQ:VIRT)

VIRT Lawsuit on behalf of: investors who purchased March 1, 2019 - April 28, 2023
Lead Plaintiff Deadline : July 18, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/virtu-lawsuit-submission-form?prid=40030&wire=1

According to the filed complaint, during the class period, Virtu Financial, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company maintained deficient policies and procedures with respect to its information access barriers; (ii) accordingly, Virtu had overstated the Company's operational and technological efficacy as well as its capacity to block the exchange of confidential information between departments or individuals within the Company; (iii) the foregoing deficiencies increased the likelihood that the Company would be subject to enhanced regulatory scrutiny; and (iv) as a result, defendants' public statements were materially false and/or misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 4th Floor Suite #427
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.